Sells test instruments to pharmaceutical manufacturers.
Jun 2026Revenue $348M/yrExpenses $337M/yr
No trend
Figures by year
Is Transcat profitable?
Yes. In the 12 months to Jun 2026, revenue was $348M and expenses $337M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Mar 2026 | $332M | $319M | $13.3M |
| Mar 2025 | $278M | $261M | $17.9M |
| Mar 2024 | $259M | $240M | $19.8M |
| Mar 2023 | $231M | $214M | $16.2M |
| Mar 2022 | $205M | $191M | $14.1M |
| Mar 2021 | $173M | $162M | $11.1M |
| Mar 2020 | $173M | $162M | $10.8M |
| Mar 2019 | $161M | $151M | $10.2M |
| Mar 2018 | $155M | $146M | $9.03M |
| Mar 2017 | $144M | $136M | $7.93M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.